Select Medical Holdings Corporation(SEM) Stock Research - Grey Stern Research

Select Medical Holdings Corporation (SEM) Stock Analysis

$21.03 (-0.38%)

SEM Financial Performance


Use the table below to view Select Medical Holdings Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $21.03 -
52 Week Low $12.40 -
52 Week High $22.08 -
Market Cap $2.7 Billion 4/8
Gross Margin 11% 8/8
Profit Margin 3% 6/8
EBITDA margin 88% 1/8
Q3 - 2024 Revenue $1.8 Billion 1/8
Q3 - 2024 Earnings $55.6 Million 4/8
Q3 - 2024 Free Cash Flow $289.0 Million 1/8
Trailing 4 Quarters Revenue $7.0 Billion 1/8
Trailing 4 Quarters Earnings $273.0 Million 3/8
Quarterly Earnings Growth 15% 7/8
Annual Earnings Growth -3% 6/8
Quarterly Revenue Growth 6% 7/8
Annual Revenue Growth 4% 7/8
Cash On Hand $191.5 Million 3/8
Short Term Debt $292.6 Million 1/8
Long Term Debt $4.3 Billion 1/8

Select Medical Holdings Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Select Medical Holdings Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 9.97 6/8
PS 0.39 8/8
PB 1.18 8/8
PC 14.22 5/8
Liabilities to Equity 2.98 1/8
ROA 0.03 5/8
ROE 0.14 2/8
Current Ratio 1.40 8/8
Quick Ratio 0.03 6/8
Long Term Debt to Equity 2.23 1/8
Debt to Equity 2.38 1/8
Burn Rate 1.02 5/8
Cash to Cap 0.07 4/8
CCR 5.20 1/8
EV to EBITDA 4.57 8/8
EV to Revenue 1.02 6/8

Company Details

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

CEO: Mr. David Chernow

Website: https://www.selectmedical.com

Address: 4714 Gettysburg Rd Mechanicsburg, PENNSYLVANIA

Exchange: New York Stock Exchange

Industry: Medical Care Facilities

Select Medical Holdings Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Select Medical Holdings Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Acadia Healthcare Company, Inc. ACHC $3.9 Billion
Encompass Health Corporation EHC $10.3 Billion
MEDNAX, Inc. MD $1.3 Billion
Addus HomeCare Corporation ADUS $2.2 Billion
The Ensign Group, Inc. ENSG $8.3 Billion
The Pennant Group, Inc. PNTG $1.1 Billion
InnovAge Holding Corp. INNV $663.7 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
SEM Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 1.8 Billion $55.6 Million
Q2 2024 $ 1.8 Billion $74.2 Million
Q1 2024 $ 1.8 Billion $96.9 Million
Q4 2023 $ 1.7 Billion $46.3 Million
Q3 2023 $ 1.7 Billion $48.2 Million
Q2 2023 $ 1.7 Billion $78.2 Million
Q1 2023 $ 1.7 Billion $70.8 Million
Q4 2022 $ 1.6 Billion $37.7 Million

View All

SEM Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $191.5 Million $8.0 Billion $4.6 Billion $1.9 Billion
Q2 2024 $111.2 Million $7.9 Billion $5.0 Billion $1.7 Billion
Q1 2024 $92.6 Million $7.9 Billion $5.1 Billion $1.7 Billion
Q4 2023 $84.0 Million $7.7 Billion $5.0 Billion $1.6 Billion
Q3 2023 $77.4 Million $7.7 Billion $5.0 Billion $1.3 Billion
Q2 2023 $101.2 Million $7.7 Billion $5.0 Billion $1.2 Billion
Q1 2023 $83.7 Million $7.7 Billion $5.1 Billion $1.4 Billion
Q4 2022 $97.9 Million $7.7 Billion $5.1 Billion $1.3 Billion

View All

SEM Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $289.0 Million $108.1 Million $80.3 Million
Q2 2024 $222.6 Million -$55.5 Million $18.5 Million
Q1 2024 -$119.2 Million -$52.5 Million $8.6 Million
Q4 2023 $118.8 Million -$60.6 Million $6.6 Million
Q3 2023 $90,300 $0 $90,300
Q2 2023 $175.3 Million -$59.5 Million $17.5 Million
Q1 2023 -$7.4 Million -$58.9 Million -$14.2 Million
Q4 2022 -$42.7 Million -$55.3 Million -$10.3 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions